Treatment of Acute Tonsillitis After Penicillin V Failure in Adults and Adolescents with β-Haemolytic Streptococcal Infection (Age 15+)

This protocol applies when first-line Penicillin V therapy for acute tonsillitis has not achieved the expected response — specifically in patients aged 15 years and older with confirmed or highly suspected β-haemolytic streptococcal infection (group A, C, or G) and a McIsaac score of at least 3.

Clinical Scenario

Highly suspected or confirmed β-haemolytic streptococcal infection (group A, C, or G)
McIsaac score of at least 3
Patient aged 15 years or older
No penicillin allergy or incompatibility

Why This Protocol Applies — Previous Line Failure

The patient received first-line treatment with Penicillin V for streptococcal tonsillitis but did not become free of symptoms within 48 hours — the expected goal of that first-line approach. This protocol addresses the next clinical step after that failure.

Next-Step Treatment Approach

For this specific situation — Penicillin V failure in an adult or adolescent with β-haemolytic streptococcal tonsillitis — a class of oral cephalosporins is among the options considered. The complete agent selection, dosing, and duration are set out in the full structured protocol.

The full evidence-based regimen, including all clinical decision points, is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1007/s00405-015-3872-6

Antibiotic therapy is indicated only in case of a highly suspected or proven b-hemolytic streptococci infection (of group A, C, or G).

For patients with sore throat in times and regions without epidemic occurrence of b-hemolytic streptococcal infection, a low regional incidence of streptococcal sequelae and a McIsaac-Score of at least 3, oral medication is recommended as follows

Age 15 years and older:

Only very selected indications support administration of oral cephalosporins (for example: cefadroxil, cefalexin) including the failure of penicillin V, frequent recurrences, and whenever a more reliable eradication of b-hemolytic streptococci is desirable.

View source ↗